A detailed history of Boston Partners transactions in Johnson & Johnson stock. As of the latest transaction made, Boston Partners holds 1,794,120 shares of JNJ stock, worth $281 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,794,120
Previous 1,819,535 1.4%
Holding current value
$281 Million
Previous $288 Million 8.9%
% of portfolio
0.34%
Previous 0.36%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $3.67 Million - $4.01 Million
-25,415 Reduced 1.4%
1,794,120 $262 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $12.2 Million - $12.8 Million
-78,543 Reduced 4.14%
1,819,535 $288 Million
Q4 2023

Feb 07, 2024

SELL
$145.6 - $158.88 $20.7 Million - $22.6 Million
-142,234 Reduced 6.97%
1,898,078 $298 Million
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $736 Million - $824 Million
-4,723,592 Reduced 69.84%
2,040,312 $318 Million
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $128 Million - $138 Million
-830,591 Reduced 10.94%
6,763,904 $1.12 Billion
Q1 2023

May 09, 2023

SELL
$151.05 - $180.26 $163 Million - $195 Million
-1,079,581 Reduced 12.45%
7,594,495 $1.18 Billion
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $58.8 Million - $65.9 Million
-366,795 Reduced 4.06%
8,674,076 $1.53 Billion
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $2.51 Million - $2.79 Million
-15,555 Reduced 0.17%
9,040,871 $1.48 Billion
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $116 Million - $129 Million
692,096 Added 8.27%
9,056,426 $1.61 Billion
Q1 2022

May 10, 2022

BUY
$158.14 - $179.59 $60.7 Million - $68.9 Million
383,705 Added 4.81%
8,364,330 $1.48 Billion
Q4 2021

Feb 04, 2022

BUY
$155.93 - $173.01 $27.3 Million - $30.3 Million
174,936 Added 2.24%
7,980,625 $1.37 Billion
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $13.6 Million - $15.2 Million
84,423 Added 1.09%
7,805,689 $1.26 Billion
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $59.8 Million - $64.2 Million
375,005 Added 5.1%
7,721,266 $1.27 Billion
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $12.7 Million - $14.2 Million
83,279 Added 1.15%
7,346,261 $1.21 Billion
Q4 2020

Feb 04, 2021

BUY
$137.11 - $157.38 $55 Million - $63.1 Million
400,945 Added 5.84%
7,262,982 $1.14 Billion
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $133 Million - $146 Million
949,327 Added 16.06%
6,862,037 $1.02 Billion
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $72.6 Million - $87.6 Million
-563,499 Reduced 8.7%
5,912,710 $832 Million
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $484 Million - $671 Million
4,358,424 Added 205.8%
6,476,209 $849 Million
Q4 2019

Feb 05, 2020

SELL
$127.5 - $146.44 $37.8 Million - $43.5 Million
-296,786 Reduced 12.29%
2,117,785 $309 Million
Q3 2019

Nov 20, 2019

SELL
$126.95 - $142.14 $1 Billion - $1.12 Billion
-7,902,956 Reduced 76.6%
2,414,571 $312 Million
Q3 2019

Nov 08, 2019

SELL
$126.95 - $142.14 $30.7 Million - $34.3 Million
-241,526 Reduced 2.29%
10,317,527 $1.44 Billion
Q2 2019

Aug 26, 2019

SELL
$131.15 - $144.24 $78,558 - $86,399
-599 Reduced 0.01%
10,559,053 $1.47 Billion
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $247 Million - $271 Million
-1,881,619 Reduced 15.12%
10,559,652 $1.47 Billion
Q1 2019

May 03, 2019

SELL
$125.72 - $139.79 $5.73 Million - $6.37 Million
-45,568 Reduced 0.36%
12,441,271 $1.74 Billion
Q4 2018

Feb 07, 2019

SELL
$122.84 - $147.84 $66.5 Million - $80.1 Million
-541,478 Reduced 4.16%
12,486,839 $1.61 Billion
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $39.9 Million - $46.9 Million
328,260 Added 2.58%
13,028,317 $1.8 Billion
Q2 2018

Aug 03, 2018

SELL
$119.4 - $131.76 $10 Million - $11 Million
-83,852 Reduced 0.66%
12,700,057 $1.54 Billion
Q1 2018

May 04, 2018

BUY
$125.1 - $148.14 $651 Million - $771 Million
5,207,124 Added 68.72%
12,783,909 $1.64 Billion
Q4 2017

Feb 01, 2018

BUY
$131.22 - $143.62 $2.19 Million - $2.4 Million
16,723 Added 0.22%
7,576,785 $1.06 Billion
Q3 2017

Nov 02, 2017

BUY
$129.47 - $135.38 $979 Million - $1.02 Billion
7,560,062
7,560,062 $983 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.